Maya H Buch

2002–2026 年に発表

別表記
Maya H. Buch
108
論文数
19,619
被引用数
56
h 指数
99
i10 指数

被引用数

Maya H Buch の年別被引用数1998 年: 被引用 2 件2003 年: 被引用 2 件2004 年: 被引用 10 件2005 年: 被引用 15 件2006 年: 被引用 18 件2007 年: 被引用 16 件2008 年: 被引用 22 件2009 年: 被引用 35 件2010 年: 被引用 41 件2011 年: 被引用 77 件2012 年: 被引用 66 件2013 年: 被引用 86 件2014 年: 被引用 112 件2015 年: 被引用 144 件2016 年: 被引用 105 件2017 年: 被引用 138 件2018 年: 被引用 87 件2019 年: 被引用 357 件2020 年: 被引用 479 件2021 年: 被引用 788 件2022 年: 被引用 713 件2023 年: 被引用 582 件2024 年: 被引用 985 件2025 年: 被引用 552 件2026 年: 被引用 21 件1999〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,228 件、この内訳の 13.7%イギリス: 引用元論文 925 件、この内訳の 10.3%中国: 引用元論文 613 件、この内訳の 6.9%イタリア: 引用元論文 572 件、この内訳の 6.4%ドイツ: 引用元論文 468 件、この内訳の 5.2%フランス: 引用元論文 449 件、この内訳の 5%オランダ: 引用元論文 425 件、この内訳の 4.8%日本: 引用元論文 390 件、この内訳の 4.4%スペイン: 引用元論文 300 件、この内訳の 3.4%カナダ: 引用元論文 299 件、この内訳の 3.3%スイス: 引用元論文 214 件、この内訳の 2.4%オーストラリア: 引用元論文 207 件、この内訳の 2.3%
0%13.7%その他 31.9%

分野

  • Medicine81.1%
  • Biochemistry, Genetics and Molecular Biology7.6%
  • Immunology and Microbiology6.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.8%
  • Computer Science0.4%
  • その他2.3%

トピック

  • Rheumatoid Arthritis Research and Therapies17.7%
  • Systemic Lupus Erythematosus Research5.6%
  • Spondyloarthritis Studies and Treatments5.5%
  • Autoimmune and Inflammatory Disorders Research5.1%
  • Systemic Sclerosis and Related Diseases2.7%
  • COVID-19 Clinical Research Studies2.1%
  • その他61.3%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 被引用: 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 被引用: 2,766

  3. EULAR definition of difficult-to-treat rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacob M. van Laar - Annals of the Rheumatic Diseases 2020 被引用: 539

  4. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Durez, Maya H Buch, Hasan Rizvi, Arti Mahto, Carlomaurizio Montecucco, Bernard Lauwerys, Nora Ng, Pauline Ho, Vasco C. Romão, João Eurico Fonseca, Patrick Verschueren, Stephen Kelly, Pier Paolo Sainaghi, Nagui Gendi, Bhaskar DasGupta, Alberto Cauli, Piero Reynolds, Juan D. Cañete, Julio Ramírez, Raquel Celis, Robert J. Moots, Peter C. Taylor, C J Edwards, John D. Isaacs, Peter Sasieni, Ernest Choy, Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Gaye Hadfield, Costantino Pitzalis - Nature Medicine 2022 被引用: 279

  5. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Thompson, Serena Bugatti, Mattia Bellan, Mattia Congia, Christopher Holroyd, Arthur G. Pratt, João Eurico Fonseca, Laura White, Louise Warren, Joanna Peel, Rebecca Hands, Liliane Fossati‐Jimack, Gaye Hadfield, Georgina Thorborn, Julio Ramírez, Raquel Celis - The Lancet 2021 被引用: 315

  6. Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis

    著者: , , - Nature Reviews Rheumatology 2020 被引用: 304

  7. Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen M. Douglas, Christos Koutsianas, Faye A. H. Cooles, Marie Falahee, Irene Echavez-Naguicnic, Anurag Bharadwaj, Michael Villaruel, Ira Pande, David Collins, Suzannah Pegler, Sabrina Raizada, Stefan Siebert, G. Fragoulis, Jesusa Guinto, James Galloway, Andrew I Rutherford, Theresa Barnes, Helen Jeffrey, Yusuf Patel, Michael Batley, Brendan O'Reilly, Srivinisan Venkatachalam, Thomas Sheeran, Claire Gorman, Piero Reynolds, Asad Khan, Nicola Gullick, Siwalik Banerjee, Kulveer Mankia, Deepak Jordan, Jane Rowlands, Mirian Starmans‐Kool, James C. Taylor, Pradip Nandi, Ilfita Sahbudin, Mark Maybury, Samantha Hider, Ann Barcroft, Jeremy McNally, Jo Kitchen, Muhammad Nisar, Vanessa Quick - The Lancet 2024 被引用: 160

  8. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2021 被引用: 276

  9. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

    著者: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 204

  10. Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

    著者: , , , , , , , , - Nature Reviews Rheumatology 2024 被引用: 128

  11. Drug-Induced Interstitial Lung Disease: A Systematic Review

    著者: , , , , , , , , , , , , , , - Journal of Clinical Medicine 2018 被引用: 408

  12. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 被引用: 858

  13. Synovial tissue research: a state-of-the-art review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2017 被引用: 257

  14. Defining refractory rheumatoid arthritis

    著者: - Annals of the Rheumatic Diseases 2018 被引用: 185

  15. Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claire Gorman, James Galloway, Hector Chinoy, Désirée van der Heijde, Peter Sasieni, Anne Barton, Costantino Pitzalis, Ahmed S Zayat, Ana Rita Marinho Machado, Andrea Cuervo, Arti Mahto, Cankut Çubuk, Charlotte Rawlings, Chijioke H Mosanya, Christopher D. Buckley, Chris Holroyd, Debbie Maskall, Francesco Carlucci, Georgina Thorborn, Gina Tan, Gloria Lliso-Ribera, Hasan Rizvi, Joanna Peel, João Eurico Fonseca, John D. Isaacs, Julio Ramírez, Laurent Méric de Bellefon, Liliane Fossati-Jimak, Mary Ng’endo Githinji, Mattia Congia, Neal L. Millar, Nirupam Purkayastha, Raquel Celis, Rakhi Seth, Rebecca Hands-Greenwood, Robert Landewé, Simone Perniola, Stefano Alivernini, Stefano Marcia, Stefano Marini, Stephen Kelly, Vasco C. Romão - The Lancet Rheumatology 2023 被引用: 68

  16. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Ashworth, Vandana Ayyar Gupta, Sonya V. Babu‐Narayan, Seb Bacon, Steve Ball, Amitava Banerjee, Mark Barber, Jessica Barrett, Marion Bennie, Colin Berry, Jennifer Beveridge, Ewan Birney, Lana Bojanić, Thomas Bolton, Anna E Bone, Jon P. Boyle, Tasanee Braithwaite, Benjamin Bray, Norman Briffa, David Brind, Katherine Brown, Maya H Buch, Dexter Canoy, Massimo Caputo, Raymond Carragher, Alan Carson, Geneviève Cézard, J Chang, Kate Cheema, Richard Chin, Yogini Chudasama, Yogini Chudasama, Emma Copland, Rebecca Crallan, Rachel Cripps, David Cromwell, Vasa Ćurčin, Gwenetta Curry, Caroline Dale, John Danesh, Jayati Das‐Munshi, Ashkan Dashtban, Alun H. Davies, Joanna M. Davies, Gareth Davies, Neil M Davies, Joshua Day, Antonella Delmestri, Spiros Denaxas, Rachel Denholm, John Dennis, Alastair K. Denniston, Salil V. Deo, Baljean Dhillon, Annemarie B Docherty, Tim Dong, Abdel Douiri, Johnny Downs, Alex Dregan, Elizabeth A. Ellins, Martha Elwenspoek, Fabian Falck, Florian Falter, Yat Yi Fan, Joseph Firth, Lorna Fraser, Rocco Friebel, Amir Gavrieli, Moritz Gerstung, Ruth Gilbert ほか 206 名 - The Lancet Digital Health 2022 被引用: 83

  17. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

    著者: , , , , , , , , - Annals of the Rheumatic Diseases 2014 被引用: 711

  18. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Krieg, R Marcolongo, Ilaria Galetti, Elisabetta Zanatta, Francesco Tona, Petar Seferović, Marco Matucci‐Cerinic - Journal of Scleroderma and Related Disorders 2021 被引用: 75

  19. 'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps

    著者: , - RMD Open 2022 被引用: 74

  20. B cell biomarkers of rituximab responses in systemic lupus erythematosus

    著者: , , , , , , , , - Arthritis & Rheumatism 2011 被引用: 236

  21. Transforming clinical trials in rheumatology: towards patient-centric precision medicine

    著者: , , - Nature Reviews Rheumatology 2020 被引用: 112

  22. Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessia Pepe, Oliver Distler, Petros P. Sfikakis, Petar Seferović, Marco Matucci‐Cerinic - Journal of Scleroderma and Related Disorders 2023 被引用: 56

  23. Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

    著者: , , , , , , , - Annals of the Rheumatic Diseases 2018 被引用: 169

  24. T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management

    著者: , , , , , , , , - Scientific Reports 2020 被引用: 42